Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 10 papers were listed this time. Here's a handful:
Greving J, Visseren F, de Wit G, et al. Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis. BMJ. 2011 Mar 30;342:d1672. PubMed PMID: 21450800.
Longworth L, Sculpher MJ, Bojke L, Tosh JC. Bridging the gap between methods research and the needs of policy makers: A review of the research priorities of the National Institute for Health and Clinical Excellence. Int J Technol Assess Health Care. 2011 Mar 29:1-8. [Epub ahead of print] PubMed PMID: 21447260.
Goossens LM, Nivens MC, Sachs P, et al. Is the EQ-5D responsive to recovery from a moderate COPD exacerbation? Respir Med. 2011 Mar 23. [Epub ahead of print] PubMed PMID: 21439807.
Le QA, Doctor JN. Probabilistic Mapping of Descriptive Health Status Responses Onto Health State Utilities Using Bayesian Networks: An Empirical Analysis Converting SF-12 Into EQ-5D Utility Index in a National US Sample. Med Care. 2011 Mar 18. [Epub ahead of print] PubMed PMID: 21422961.